The goal of this retrospective study is to identify the incidence of hernia recurrence following the application of Histoacryl® Lapfix - Cannula for laparoscopic mesh fixation in patients undergoing hernia repair surgery. All adult patients who underwent laparoscopic inguinal hernia repair with Histoacryl® Lapfix - Cannula in the period June 2018 - March 2021 at Hospital San Juan de Dios will be analysed. The investigator team will access electronical medical records for the cohort of patients identified.
Study Type
OBSERVATIONAL
Enrollment
443
In recent years, atraumatic mesh fixation with tissue adhesive has increasingly become the method of choice. It is the recommended mesh fixation method by the International Hernia Society Guidelines. In this study patients with inguinal hernia are treated by placing a prosthetic mesh in one of the layers of the abdominal wall to cover the weakness, the mesh is fixed by Histoacryl LapFix,
Hospital San Juan de Dios
Santa Cruz de Tenerife, Tenerife, Spain
Hernia recurrence rate
Describe the incidence of hernia recurrence following the application of Histoacryl® LapFix - Cannula for laparoscopic mesh fixation in patients undergoing hernia repair surgery. The incidence of hernia recurrence is documented from the medical records until 6 months postoperatively.
Time frame: until 6 months postoperatively
Delayed tissue adhesive polymerization
The polymerization time of Histoacryl® (about 30 seconds) takes longer than expected.
Time frame: intraoperatively
Intraoperative bleeding requiring therapeutic measures
Bleeding that requires additional measures than normal practice for stopping the hemorrhage.
Time frame: intraoperatively
Organ injury
Cumulative Number of patients suffering from Injury of an organ adjacent to the defect.
Time frame: intraoperatively
Hernia recurrence
Cumulative Number of Hernia recurring again after repair
Time frame: at discharge and 1 month postoperatively. There is the possibility to extend the follow-up period until 6 months
Mesh migration
Cumulative Number of patients in whom Mesh has moved from its original position
Time frame: at discharge and 1 month postoperatively. There is the possibility to extend the follow-up period until 6 months
Adhesions
Cumulative Number of patients in whom tissue is adhered and allows no physiological movement
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: at discharge and 1 month postoperatively. There is the possibility to extend the follow-up period until 6 months
Erosion
Cumulative Number of patients suffering from a mesh erosion into the bladder/urethra include painful voiding, urinary frequency, urgency, hematuria, recurrent urinary tract infection, urinary calculi and urinary fistula.
Time frame: at discharge and 1 month postoperatively. There is the possibility to extend the follow-up period until 6 months
Meshoma formation
Cumulative Number of patients suffering from a wrinkling of the mesh that causes pain or hernia recurrence. Nerve entrapment or damage. Rejection of the mesh implant.
Time frame: at discharge and 1 month postoperatively. There is the possibility to extend the follow-up period until 6 months
Tack hernias
Cumulative Number of patients requiring tack fixation was needed
Time frame: at discharge and 1 month postoperatively. There is the possibility to extend the follow-up period until 6 months
Surgical Site Infection (superficial, deep, intraabdominal)
Cumulative Number of patients suffering from Surgical Site Infection classified according on Center for Disease Control and Prevention criteria (A1: superficial, A2: deep, A3: organ/space)
Time frame: at discharge and 1 month postoperatively. There is the possibility to extend the follow-up period until 6 months
Hematoma
Cumulative Number of patients suffering from a solid swelling of clotted blood within the tissues.
Time frame: at discharge and 1 month postoperatively. There is the possibility to extend the follow-up period until 6 months
Seroma
Cumulative Number of patients suffering from a mass or lump caused by a buildup of clear fluid in a tissue, organ or body cavity
Time frame: at discharge and 1 month postoperatively. There is the possibility to extend the follow-up period until 6 months
Hemorrhage
Cumulative Number of patients suffering from an escape of blood from a ruptured blood vessel.
Time frame: at discharge and 1 month postoperatively. There is the possibility to extend the follow-up period until 6 months
Orchitis
Cumulative Number of patients suffering from inflammation of the testicles
Time frame: at discharge and 1 month postoperatively. There is the possibility to extend the follow-up period until 6 months
Other Adverse Event
Cumulative Number of any other adverse event not mentioned.
Time frame: at discharge and 1 month postoperatively. There is the possibility to extend the follow-up period until 6 months
Reintervention
Patient requiring to be operated again for any reason.
Time frame: until 6 months postoperatively
Mesh repositioning or removal
Patient requiring being operated again for repositioning or removal of the Mesh
Time frame: until 6 months postoperatively
Acute or chronic pain
pain persisting beyond 6 months postoperatively re-quiring analgesic treatment
Time frame: until 6 months postoperatively